DCM
Driehaus Capital Management Portfolio holdings
AUM
$12.5B
1-Year Return
79.21%
This Quarter Return
-10.33%
1 Year Return
+79.21%
3 Year Return
+526.69%
5 Year Return
+1,716.36%
10 Year Return
+17,720.68%
AUM
$6.17B
AUM Growth
-$1.97B
(-24%)
Cap. Flow
-$758M
Cap. Flow
% of AUM
-12.27%
Top 10 Holdings %
Top 10 Hldgs %
17.81%
Holding
469
New
91
Increased
125
Reduced
120
Closed
117
Top Buys
| 1 |
FTI Consulting
FCN
|
$59.5M |
| 2 |
Xenon Pharmaceuticals
XENE
|
$33.2M |
| 3 |
America Movil
AMX
|
$30.8M |
| 4 |
XPeng
XPEV
|
$30.6M |
| 5 |
MGP Ingredients
MGPI
|
$29.3M |
Top Sells
| 1 |
Infosys
INFY
|
$85.8M |
| 2 |
United Parks & Resorts
PRKS
|
$64.2M |
| 3 |
Vale
VALE
|
$56.2M |
| 4 |
Spirit AeroSystems
SPR
|
$46M |
| 5 |
Micron Technology
MU
|
$44.7M |
Sector Composition
| 1 | Healthcare | 23.12% |
| 2 | Technology | 17.89% |
| 3 | Industrials | 14.18% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Financials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Saia
SAIA
$8.34B
| – | – |
-47,658
| Closed | -$11.6M |
|
352
Alcoa
AA
$8.24B
| – | – |
-5,146
| Closed | -$463K |
|
353
Ally Financial
ALLY
$12.7B
| – | – |
-113,665
| Closed | -$4.94M |
|
354
Amgen
AMGN
$153B
| – | – |
-137,830
| Closed | -$33.3M |
|
355
Alpha Metallurgical Resources
AMR
$1.91B
| – | – |
-28,678
| Closed | -$3.78M |
|
356
Alpha and Omega Semiconductor
AOSL
$839M
| – | – |
-172,275
| Closed | -$9.42M |
|
357
A.O. Smith
AOS
$10.3B
| – | – |
-130,732
| Closed | -$8.35M |
|
358
Amphenol
APH
$135B
| – | – |
-5,784
| Closed | -$218K |
|
359
Arvinas
ARVN
$575M
| – | – |
-84,892
| Closed | -$5.71M |
|
360
AdvanSix
ASIX
$569M
| – | – |
-157,383
| Closed | -$8.04M |
|
361
ASML
ASML
$307B
| – | – |
-44,070
| Closed | -$29.4M |
|
362
Acuity Brands
AYI
$10.4B
| – | – |
-50,796
| Closed | -$9.62M |
|
363
Ball Corp
BALL
$13.9B
| – | – |
-429,897
| Closed | -$38.7M |
|
|
BCYC
364
Bicycle Therapeutics
BCYC
$496M
| – | – |
-229,290
| Closed | -$10.1M |
|
|
BPMC
365
DELISTED
Blueprint Medicines
BPMC
| – | – |
-133,690
| Closed | -$8.54M |
|
366
Brilliant Earth
BRLT
$41.3M
| – | – |
-1,069,291
| Closed | -$11M |
|
367
Dutch Bros
BROS
$8.38B
| – | – |
-256,096
| Closed | -$14.2M |
|
368
BlueLinx
BXC
$680M
| – | – |
-168,519
| Closed | -$12.1M |
|
369
Camtek
CAMT
$3.6B
| – | – |
-185,804
| Closed | -$5.66M |
|
370
Carlyle Group
CG
$23.1B
| – | – |
-4,428
| Closed | -$217K |
|
371
Choice Hotels
CHH
$5.41B
| – | – |
-3,828
| Closed | -$543K |
|
372
Celldex Therapeutics
CLDX
$1.52B
| – | – |
-292,292
| Closed | -$9.96M |
|
373
Cleveland-Cliffs
CLF
$5.63B
| – | – |
-201,355
| Closed | -$6.49M |
|
374
Comcast
CMCSA
$125B
| – | – |
-4,743
| Closed | -$222K |
|
|
CNTA
375
Centessa Pharmaceuticals
CNTA
$2.11B
| – | – |
-1,053,142
| Closed | -$9.45M |
|